

Xromi 羟基脲口服液

通用中文 | 羟基脲口服液 | 通用外文 | hydroxycarbamide |
品牌中文 | 品牌外文 | Xromi | |
其他名称 | 羟基脲 | ||
公司 | 诺华(Novartis) | 产地 | 爱尔兰(Ireland) |
含量 | 100mg/ml, 100ml | 包装 | 1瓶/盒 |
剂型给药 | 口服液体 | 储存 | 室温 |
适用范围 | 预防2岁以上患者的镰状细胞病的血管闭塞性并发症 |
通用中文 | 羟基脲口服液 |
通用外文 | hydroxycarbamide |
品牌中文 | |
品牌外文 | Xromi |
其他名称 | 羟基脲 |
公司 | 诺华(Novartis) |
产地 | 爱尔兰(Ireland) |
含量 | 100mg/ml, 100ml |
包装 | 1瓶/盒 |
剂型给药 | 口服液体 |
储存 | 室温 |
适用范围 | 预防2岁以上患者的镰状细胞病的血管闭塞性并发症 |
2019年4月26日,人用药品委员会(CHMP)采纳了积极意见,建议批准药品Xromi的上市许可,旨在预防患者的镰状细胞病血管闭塞并发症。 2岁。该药品的申请人是Nova Laboratories Ireland Limited。
Xromi将以100 mg / ml口服溶液的形式提供。 Xromi的活性物质是羟基脲,一种核糖核苷酸还原酶抑制剂(ATC代码:L01XX05),其通过干扰DNA的合成起作用,而不干扰核糖核酸或蛋白质的合成。
Xromi的好处是能够减少镰状细胞病的血管闭塞并发症。最常见的副作用是骨髓抑制,包括中性粒细胞减少症,网状细胞减少症,大红细胞增多症,血小板减少症,贫血症,头痛,头晕,恶心,便秘,皮肤溃疡,口腔,指甲和皮肤色素沉着,皮肤干燥和脱发。
Xromi是Hydrea的混合药物1,自1986年5月29日起在欧盟获得批准.Xromi含有与Hydrea相同的活性物质,但获得了不同的适应症。 Hydrea被授权治疗某些癌症。
完整的适应症是:“预防2岁以上患者的镰状细胞病的血管闭塞性并发症。”建议Xromi由医生或其他有镰状细胞病患者管理经验的医疗专业人员开处方。
有关使用本产品的详细建议将在产品特性摘要(SmPC)中进行描述,该摘要将在欧洲公共评估报告(EPAR)中公布,并在获得上市许可后以所有欧盟官方语言提供。由欧洲委员会。
Xromi® (Hydroxycarbamide)
100 mg/ml oral solution
Patient / Parent Guide
Important safety information about serious side effects that you need to be aware of before, during and after treatment
XromUK001 September 2019 (Patient/Parent Guide)
|
|
Page. |
1. |
Why your doctor has prescribed Hydroxycarbamide |
3. |
|
|
|
2. |
Hydroxycarbamide must be handled with care |
4. |
|
- Handling |
|
|
|
|
3. |
When you are treated with Hydroxycarbamide it is very important to be regularly monitored |
8. |
|
by your doctor |
|
3.1Reduced production of blood cells in the bone marrow (the soft, organic, sponge like material in the cavities of bones)
- Other medicines that reduce the production of blood cells in the bone marrow and radiotherapy treatment
3.2Use with medicines that inhibit or destroy a retrovirus such as HIV
3.3Ulcers of the skin and inflammation of blood vessels
3.4Long term safety
- Hydroxycarbamide may affect the DNA synthesis. Development of cancer such as skin cancer and secondary cancers e.g. secondary leukaemia in elderly patients
3.5Use of hydroxycarbamide if you have liver and/or kidney disease
3.6Effect of hydroxycarbamide on the development of the foetus (birth defects); male fertility; need for contraception; breastfeeding
(i) If you are a man
(ii) If you are a woman of childbearing potential
3.7Influence on the growth of the children and adolescents
4. Side effects which have been observed with Hydroxycarbamide |
12. |
-Key signs and symptoms of serious adverse reactions |
|
5. Important signs and symptoms of the disease |
13. |
- Acute painful crises
- When to seek urgent attention from healthcare provider
- Infections
6. Patient information leaflet |
15. |
2 XromUK001 September 2019 (Patient/Parent Guide)
1. Why your doctor has prescribed Hydroxycarbamide
Your doctor has prescribed Hydroxycarbamide for you or your child to treat
a condition called sickle cell disease. This is an inherited disease that affects the red cells of the blood. Some cells become abnormal, rigid and take a crescent or sickle shape which leads to anaemia. The sickle cells also get stuck in blood vessels, blocking blood flow. This can cause acute pain crises and organ damage
Hydroxycarbamide is used to prevent the complications of blocked blood vessels caused by sickle cell disease in patients over 2 years of age
Hydroxycarbamide will decrease the number of painful crises as well as the need for hospitalisation as a result of the disease
Hydroxycarbamide has been prescribed for you. Never give it to someone else, even if he or she has the same disorder for which you are being treated
Take this medication exactly as it has been prescribed for you by your doctor.
Take your treatment regularly and do not change the dose yourself
Hydroxycarbamide may interact with other medicines and live virus vaccines. Please tell your doctor if you are taking or have recently taken any other medicines, even those obtained without a prescription. Please tell your doctor if you have had or are due to have any vaccsles, mumps, rubella (MMR), chicken pox)
Before starting the treatment, read the package leaflet present
in each box of Hydroxycarbamide
3 XromUK001 September 2019 (Patient/Parent Guide)
2. Hydroxycarbamide must be handled with care
Please use the syringe as advised by your doctor or pharmacist
Ask your doctor or pharmacist if you have any questions
Each pack contains one bottle 150 ml capped with a child-resistant closure, a bottle adaptor and two dosing syringes (a red syringe graduated to 3 ml and a white syringe graduated to 12 ml)
Packaging
Contents
Bottle
12 ml syringe(white)
(for doses more than 3 ml)
Bottle adaptor
3 ml syringe(red)
(for doses less than
or equal to 3 ml)
|
|
Syringe Type |
|
|
|
|
|
Syringe volume |
3 ml |
|
12 ml |
|
|
|
|
Colour |
Red |
|
White |
|
|
|
|
Measurements |
0.5 ml to 3 ml |
|
1 ml to 12 ml |
|
|
|
|
Your doctor or pharmacist will advise which syringe to use depending on the dose that has been prescribed
4 XromUK001 September 2019 (Patient/Parent Guide)
Women who are pregnant, planning to be or breastfeeding should not handle Hydroxycarbamide
Hydroxycarbamide may be taken with or after meals at any time of the day.However, the choice of method and time of day should be consistent from day to day
Water should be taken after each dose of Hydroxycarbamide, to assist accurate and consistent dose delivery to the stomach
Keep out of the sight and reach of children. Accidental ingestion can be lethal for children
Store in a refrigerator (2°C - 8°C). After first opening of the bottle, discard any unused contents after 12 weeks
Keep the bottle tightly closed to prevent spoilage of the medicine and reduce the risk of accidental spillage. To minimise air bubbles, the bottle shouldnot be shaken prior to dosing
5 XromUK001 September 2019 (Patient/Parent Guide)
1. Wash your hands before and after administering a dose. Wipe up spillages immediately
4. Push the adaptor firmly into the top of the bottle and leave in place for future doses
2. Put on disposable hand gloves to decrease the risk of exposure
5. Push the tip of the dosing syringe into the hole in the adaptor. Your doctor or pharmacist will advise you of the correct syringe to use, either the 3 ml (red syringe) or the 12 ml (white syringe) in order to give the correct dose
3. Remove the bottle
6. Turn the bottle upside down. Pull the plunger of the syringe back so that the medicine is drawn from the bottle into the syringe. Pull the plunger back to the point on the scale that corresponds to the dose prescribed
If you are not sure about how much medicine to draw into the syringe,
always ask your doctor or nurse for advice
7. Turn the bottle back the right way up and carefully remove the syringe from the adaptor, holding it by the barrel rather than the plunger
8. Gently put the tip of the syringe into your mouth and to the inside of your cheek
9. Slowly and gently push the plunger down to gently squirt the medicine into the inside of your cheek and swallow it. DO NOT forcefully push down the plunger, or squirt the medicine to the back of your mouth or throat, as you may choke
6 XromUK001 September 2019 (Patient/Parent Guide)
10. Remove the syringe from your mouth
11. Swallow the dose of oral solution then drink some water, making sure no medicine
is left in your mouth
12. Put the cap back on the bottle with the adaptor left in place. Ensure that the cap is tightly closed
13. Wash the syringes with cold or warm tap water and rinse well. Hold the syringe under water and move the plunger up and down several times to make sure the inside of the syringe is clean. Let the syringe dry completely before you use it again
14. Store the syringe in a hygienic place with the medicine
Wash immediately and thoroughly with soap and water if Hydroxycarbamide
comes into contact with skin, eyes or nose
7 XromUK001 September 2019 (Patient/Parent Guide)
3. When you are treated with Hydroxycarbamide, it is very important to be regularly monitored by your doctor
3.1 Reduced production of blood cells in the bone marrow (the soft, organic, sponge like material in the cavities of bones)
When you take Hydroxycarbamide your doctor will need to take regular blood tests, to check the number and type of cells in your blood
These tests may be performed
Initially every two weeks and then every 2-3 months
Depending on these results your doctor may change your dose or temporarily withhold the dosing
- Other medicines that reduce the production of blood cells in the bone marrow and radiotherapy treatment
You will have to talk to your doctor, pharmacist or nurse before taking Hydroxycarbamide
If you are taking other myelosuppressive medicines (medicines that decrease production of red, white, or coagulating blood cells)
If you are receiving radiation therapy, chemotherapy, or are currently taking any medicines for cancer treatment (especially interferon therapy)
When used with Hydroxycarbamide
There is greater chance of bone marrow depression, gastro-intestinal disturbances and soreness and inflammation of the mouth and gut
Redness of the skin may reoccur when Hydroxycarbamide is given to patients who have received irradiation therapy in the past
3.2 Use with medicines that inhibit or destroy a retrovirus such as HIV
Tell your doctor, nurse or pharmacist if you are taking any antiretroviral medicines (those that inhibit or destroy a retrovirus such as HIV), e.g. didanosine, stavudine and indinavir
Hydroxycarbamide should not be used in combination with antiretroviral agents for HIV diseaseA drop in your white cell count, severe liver damage and failure and peripheral neuropathy may occur
8 XromUK001 September 2019 (Patient/Parent Guide)
3.3 Ulcers of the skin and inflammation of blood vessels
Ulcers
Talk to your doctor, pharmacist or nurse before taking Hydroxycarbamide if you have leg ulcers or wounds
Leg ulcers are a common complication of sickle cell disease, but have also been reported in patients treated with hydroxycarbamide. In patients with leg ulcers, hydroxycarbamide should be used with caution
Talk to your doctor if you develop inflammation or ulceration of the mouth (oral mucositis) when treated with Hydroxycarbamide
Inflammation of the blood vessels (vasculitis)
During therapy with hydroxycarbamide, vasculitis in the skin (which can sometimes lead to ulcers and gangrene) has occurred in patients with myeloproliferative disorders
The risk is increased in patients who have previously received or are receiving interferon therapy
Hydroxycarbamide should be discontinued if skin ulcers develop
3.4 Long term safety
- Hydroxycarbamide may affect the DNA synthesis.
Development of cancer such as skin cancer and secondary cancers e.g. secondary leukaemia in elderly patients
Hydroxycarbamide may potentially affect DNA synthesis causing damage to the cells In patients receiving long-term hydroxycarbamide there have been reports of
Skin cancer
Please protect your skin from sun exposure, conduct self-inspection of the skin and be screened for secondary malignancies during your routine follow-up visits to the doctor (especially if you are older)
Isolated cases of cancer of blood cells (leukaemia)
In some patients receiving long-term therapy with hydroxycarbamide for various types of blood tumours, secondary leukaemia has been reported
It is unknown whether this is due to hydroxycarbamide or is a consequence of the patient’s underlying disease
9 XromUK001 September 2019 (Patient/Parent Guide)
3.5 Use of hydroxycarbamide if you have liver and/or kidney disease
Please talk to your doctor pharmacist or nurse if you have any liver or kidney disease
If you have kidney disease your doctor may need to give you a lower dose Hydroxycarbamide should be used with caution in patients with marked kidney disease
Do not take Hydroxycarbamide if you suffer from severe liver disease or/and severe kidney disease
Your kidney and liver function should be checked prior to, and repeatedly during treatment with hydroxycarbamide
Discontinue Hydroxycarbamide immediately if jaundice becomes apparent
3.6 Effect of hydroxycarbamide on the development of the foetus (birth defects); male fertility; need for contraception; breastfeeding
Talk to your doctor, nurse or pharmacist concerning the use of contraceptive measures before and during treatment with Hydroxycarbamide
Hydroxycarbamide is an active substance which may cause changes to the DNA (mutagenic)
The use of effective contraception before and during treatment is strongly
recommended for both male and female patients
(i) If you are a man
Hydroxycarbamide may decrease your ability to father children (fertility) while you are treated
It is important for you to know that Hydroxycarbamide may decrease sperm production and harm your sperm
Absence or low amount of sperm in the semen (azoospermia or oligospermia) is a very common side effect of hydroxycarbamide. These disorders can be also associated with
the underlying disease. Although in general reversible, it has to be taken into account when fatherhood is desired
Talk to your doctor or nurse if this is a concern for you. Your doctor can inform you about the possibility of sperm conservation (cryopreservation) before the start of therapy
10 XromUK001 September 2019 (Patient/Parent Guide)
(ii) If you are a woman of childbearing potential
Do not take Hydroxycarbamide if you are planning to have a baby without first speaking to your doctor for advice
Hydroxycarbamide should be stopped 3 to 6 months prior to becoming pregnant, if possible
Hydroxycarbamide can potentially cause foetal harm (birth defects) when administered to a pregnant woman, as it can cross the placental barrier
It may affect the DNA synthesis and as it is toxic to the cells (cytotoxic) it can potentially produce birth defects (teratogenic effect)
Hydroxycarbamide must not be used during pregnancy
If you become pregnant while you are still taking Hydroxycarbamide, please contact your doctor immediately
Please contact your doctorimmediately if you think you may be pregnant
Breastfeeding
Hydroxycarbamide is excreted in human breast milk. You should not breastfeed during the treatment
You should not handle Hydroxycarbamide if you are pregnant, planning to be or breastfeeding
3.7 Influence on the growth of the children and adolescents
The doctor will monitor growth (height and weight) in children and adolescents, as it can be affected in patients with sickle cell disease. Currently, it is not known whether Hydroxycarbamide can impact children’s growth
11 XromUK001 September 2019 (Patient/Parent Guide)
been observed with Hydroxycarbamide
Like all medicines, Hydroxycarbamide can cause side effects (although not everybody gets them). If any of these side effects become serious, or if you notice any side effects not listed here, please tell your doctor or pharmacist
- Key signs and symptoms of serious adverse reactions
If you get any of the following side effects, talk to your doctor or go to hospital immediately
A severe infection
Fever or chills
Tiredness and/or looking pale
Unexplained bruising (accumulation of blood under the skin) or bleeding Any yellowing of the whites of the eyes or skin (jaundice)
Inflammation of the skin causing red scaly patches and possibly occurring together with pain in the joints
Ulcers or wounds on legs
Sore (open skin infection) on your skin
12 XromUK001 September 2019 (Patient/Parent Guide)
5. Important signs and symptoms of the disease
Some signs and symptoms may require you to call a doctor or to visit an emergency department
These may be caused by disease progression or show that your treatment is not working or be a side effect linked to the medicinal product
You should never hesitate to discuss your condition, or your treatment with any doctor, especially if it is not your usual doctor. This will help the doctor to choose the right treatment and to administer it more rapidly
- Acute painful crises
This is referred to as an episode of extreme pain, and is the major symptom of the sickle cell disease which can start in childhood or adulthood
The pain which affects mainly the bones and joints, is often difficult to relieve by usual painkillers (analgesics). Other organs may be affected (lungs, kidneys, brain, inner ear, etc.), which explains why the symptoms vary greatly between patients. The crises may occur suddenly and resolve rapidly or last several days. The episodes of acute pain may occur several times a year. For severe painful crises, most patients require hospitalisation
- When to seek urgent attention from healthcare provider
Seek urgent attention from a healthcare provider in the following cases
Pain which is not relieved by usual painkillers (analgesics)
Your temperature is above 38.5°C, even if there is no pain
Vomiting
A sudden pallor, fatigue or impairment of your health status, a sudden increase of the volume of your spleen (your doctor will tell you how to palpate your spleen)
If you are a man and you have an involuntary, painful erection which lasts for more than three hours (priapism)
When the vaso-occlusive crises affect the lungs, it is called “acute chest syndrome” (ACS):
The patient has chest pains, fever and difficult breathing. He/she is out of breath.
This can occur in both adults and children. If it does, a doctor must be seenurgently
13 XromUK001 September 2019 (Patient/Parent Guide)
When you have sickle cell disease, you are more susceptible to infections (illness with fever). This is mainly because your spleen is less effective at filtering out certain types of bacteria. Any infection can trigger a vaso- occlusive crisis or an acute chest syndrome. It is therefore important for you to consult your doctor if you have a fever or any other sign or symptom of infection
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible side effects not listed in this leaflet.
You can also report side effects directly via the Yellow Card Scheme
Website: www.mhra.gov.uk/yellowcard or search forMHRA Yellow Card in the Google Play or Apple App Store
By reporting side effects you can help provide more information on the safety of this medicine
14 XromUK001 September 2019 (Patient/Parent Guide)
6. Patient Information Leaflet
The patient information leaflet (PIL) is available on the Electronic Medicines Compendium (www.medicines.org.uk) athttps://www.medicines.org.uk/emc/product/10549/pil
15 XromUK001 September 2019 (Patient/Parent Guide)